ScoreWhy is Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 20.69% and Operating profit at -8.76% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 2.94% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 20.69% and Operating profit at -8.76% over the last 5 years
3
Negative results in Sep 25
- NET PROFIT(HY) At CNY 1.95 MM has Grown at -88.52%
- ROCE(HY) Lowest at -0.27%
- DEBT-EQUITY RATIO (HY) Highest at 196.3 %
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -6.14%, its profits have fallen by -52.9%
- At the current price, the company has a high dividend yield of 0.2
5
Below par performance in long term as well as near term
- Along with generating -6.14% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd.
-2.66%
0.45
45.19%
China Shanghai Composite
16.01%
1.03
14.98%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
20.69%
EBIT Growth (5y)
-8.76%
EBIT to Interest (avg)
2.63
Debt to EBITDA (avg)
8.51
Net Debt to Equity (avg)
1.70
Sales to Capital Employed (avg)
0.96
Tax Ratio
33.82%
Dividend Payout Ratio
63.21%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.51%
ROE (avg)
2.94%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
89
Industry P/E
Price to Book Value
1.32
EV to EBIT
61.65
EV to EBITDA
20.17
EV to Capital Employed
1.11
EV to Sales
1.01
PEG Ratio
NA
Dividend Yield
0.18%
ROCE (Latest)
1.81%
ROE (Latest)
1.48%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 66.95 MM
DIVIDEND PAYOUT RATIO(Y)
Highest at 107.32%
RAW MATERIAL COST(Y)
Fallen by -16.72% (YoY
DIVIDEND PER SHARE(HY)
Highest at CNY 2.26
NET SALES(Q)
Highest at CNY 1,421.75 MM
PRE-TAX PROFIT(Q)
Highest at CNY 19.22 MM
-19What is not working for the Company
NET PROFIT(HY)
At CNY 1.95 MM has Grown at -88.52%
ROCE(HY)
Lowest at -0.27%
DEBT-EQUITY RATIO
(HY)
Highest at 196.3 %
INTEREST(Q)
At CNY 24.75 MM has Grown at inf%
INTEREST COVERAGE RATIO(Q)
Lowest at 161.8
INVENTORY TURNOVER RATIO(HY)
Lowest at 5.1 times
OPERATING PROFIT(Q)
Lowest at CNY 40.04 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 2.82 %
Here's what is working for Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd.
Operating Cash Flow
Highest at CNY 66.95 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
Highest at CNY 1,421.75 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Pre-Tax Profit
Highest at CNY 19.22 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Dividend per share
Highest at CNY 2.26
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (CNY)
Dividend Payout Ratio
Highest at 107.32%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Raw Material Cost
Fallen by -16.72% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd.
Net Profit
At CNY 1.95 MM has Grown at -88.52%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 24.75 MM has Grown at inf%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest Coverage Ratio
Lowest at 161.8
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Debt-Equity Ratio
Highest at 196.3 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Profit
Lowest at CNY 40.04 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 2.82 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Inventory Turnover Ratio
Lowest at 5.1 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
